Veritas In Silico Inc.
Notice Concerning Achievement of Research Milestone under Joint Drug Discovery with Toray Industries, Inc.
Filed with TSE ·
6ix is reading this filing.
View original source (TDnet)Veritas In Silico Inc. on 6ix
Earlier from Veritas In Silico
- Non-consolidated Financial Results for the Six Months Ended June 30, 2026 [Under Japanese GAAP]
- Joint Patent Application Filed for lncRNA-Targeting Drugs
- Personnel Changes in Executive Officer
- TABLE-Veritas In Silico -2025 parent results
- TABLE-Veritas In Silico - 9-MTH parent results
Follow Veritas In Silico into a list and get an email when it puts out news.
Follow Veritas In Silico